Full Press Release Details
Blog Post
| November 14, 2023
Vivani Medical Provides Business Update and Reports Third Quarter Financial Results
Read More
Previous Article
Next Article
Blog Navigation
VANI Neutral Sentiment
Vivani Medical Provides Business Update and Reports Third Quarter Financial Results
Key Takeaway: Vivani Medical has released a business update along with its financial results for the third quarter. The announcement includes insights into the company's current operations and financial performance. Further details on the implications of these results were not provided in the article.
Price reaction · baseline $1.02 (2023-11-13 close) · hit pre-market · clean, no other VANI news in the window
day 0 close
-6.3%
day 1 · peak
-6.9%
day 3
-4.1%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceCash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight